Authors




Kenneth Finegold, PhD

Latest:

Projected US Savings From Biosimilars, 2021-2025

Projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry. Savings were $124.5 billion under an upper-bound scenario.


Ya-Ping Su, PhD

Latest:

Transitional Care Management Visits to Improve Coordination of Care

Inspira Care Connect, LLC, an accountable care organization, incorporated transitional care management services into its postdischarge follow-up process to prevent avoidable utilization of health care services and costs.


Calvin L. Colvin, MSPH

Latest:

Diabetes, Gaps in Care Coordination, and Preventable Adverse Events

The authors examined the association of diabetes with self-reported gaps in care coordination and self-reported preventable adverse events using data from a national sample of older adults.


Parth K. Modi, MD, MS

Latest:

Medicare Accountable Care Organizations Reduce Spending on Surgery

Medicare Shared Savings Program accountable care organizations spent less on surgical care by reducing inpatient surgery, increasing outpatient surgery, and reducing spending on postacute care after inpatient surgery.


Laura R. Bobolts, PharmD, BCOP

Latest:

How AI, Data Analytics, and Outcomes-Based Contracts Are Shaping Health Care: Laura Bobolts, PharmD, BCOP

Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth, shares how health care leaders are advancing value-based care through improved data strategies, real-world evidence, and AI-driven efficiencies, without losing the human touch.


Cathy Moffitt, MD, FAAP, CHIE

Latest:

Contributor: Transforming Prior Authorization to Facilitate Quality Care

Payers must continue to assess their prior authorization practices to uphold the goals of clinical quality, safety, and utilization management.


Joanna B. Ringel, MPH

Latest:

Gaps in the Coordination of Care for Older Adults With or at Risk for Cardiovascular Disease

Older adults with cardiovascular disease (CVD) or CVD risk factors report that gaps in communication among their providers are common and hazardous.


Jeffrey S. Stein, PhD

Latest:

A “Sludge Audit” for Health System Colorectal Cancer Screening Services

A systematic, mixed methods “sludge audit” identified novel health system delivery targets for improving colorectal cancer screening services.


Taeko Minegishi, PhD, MS

Latest:

Regional Market Factors and Patient Experience in Primary Care

Patient-provider communication quality metrics at safety net hospitals are indirectly affected by changes in regional market factors that influence patients’ demand for care.


Isaac A. Janson, PhD

Latest:

An Outpatient Critical Care Transition Clinic Model Reduces Admissions/Readmissions in Medically Complex Patients

Critical care transition clinic patients with chronic conditions had a 31% reduction in relative risk for inpatient admissions, and the clinic reduced cost by more than $1 million.


Geoffrey T. Manley, MD, PhD

Latest:

Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury

Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.


David Blahnik, BS

Latest:

Policy Solutions to Facilitate the New eCQM ACO Reporting and Advancement of Interoperability

This article describes the challenges associated with aggregating and reporting quality data via electronic health records and discusses corresponding policy solutions.


Leena Choi, PhD

Latest:

Rheumatoid Arthritis Medication Adherence in a Health System Specialty Pharmacy

Integrated health system specialty pharmacies provide specialized services to patients, resulting in high rates of adherence to and financial assistance with specialty disease-modifying antirheumatic drugs.


David Seo, MD

Latest:

Social Determinants of Health Score: Does It Help Identify Those at Higher Cardiovascular Risk?

Calculating a social score is feasible and it predicts cardiovascular outcomes. In order to do this, institutions have to collect social determinants of health.


Amanda Conschafter, MAT

Latest:

Utilization Management and Physician Burnout

This survey assesses physician experiences with utilization management and burnout and investigates whether there is a link between them.


Lauren Oshman, MD, MPH, DABOM

Latest:

Understanding Insurance Coverage Policies for Incretin Mimetics for Weight Management

The high cost of incretin mimetics for weight management limits insurance coverage and potentiates variation in utilization management strategies to control near-term spending.


Rim A. Elbeshbeshy, PharmD

Latest:

Rituximab Reference vs Biosimilar Utilization for Oncology vs Nononcology Indications

Reporting on the real-world utilization of reference rituximab and its biosimilars can help show prescribing habits and reveal cost-saving opportunities.


Mohammad A. Chaudhary, PhD

Latest:

Cost-effectiveness of Nivolumab in Patients With NSCLC in the United States

This article presents a cost-effectiveness analysis of nivolumab vs docetaxel from the US payer perspective in non–small cell lung cancer (NSCLC) based on randomized phase 3 studies with a minimum 5 years of follow-up.


Desiree Vuocolo Canovic

Latest:

Transitions of Care: Supporting Patients and Physician Partners

An emphasis on transitions of care should ensure the highest level of care for patients and provide support to physicians.


Harold E. Kooreman, MA, MSW

Latest:

Assessment of Structured Data Elements for Social Risk Factors

An expert panel identified and assessed electronic health record and health information exchange structured data elements to support future development of social risk factor computable phenotyping.


Sharon K. Jhawar, PharmD, MBA, BCGP

Latest:

Rethinking Deprescribing: Who Should Monitor “Drug Overload”?

Health plan pharmacists are in the perfect position to see overprescribing as it happens.


Jiat-Ling Poon, PhD

Latest:

Activation, Physical Activity, and Outcomes Among Individuals With T2D

This study presents an integrated, exploratory assessment of physical activity, patient activation, health-related quality of life, and clinical outcomes among older adults with type 2 diabetes (T2D) using survey, wellness, and claims data.


Celeste Krewson

Latest:

HPV 16 and 18 Linked to Ovarian Cancer Risk

In a recent meta-analysis, the prevalence of human papillomavirus (HPV), especially types 16 and 18, was significantly increased among patients with ovarian cancer (OC) vs controls.


Amanda C. Chen, MS

Latest:

Medical Loss Ratio’s Role in the Large Group Insurer Market

The authors used medical loss ratio forms to assess trends in premiums, medical claims, administrative costs, quality improvement, and margins in the large group insurer market.


M. Ella Lewie, MSW, LSW

Latest:

Potential Health Literacy Resources for Health Plans: A Narrative Review

Several evidence-based health literacy resources may be beneficial in health plan settings to improve organizational health literacy, personal health literacy, and health equity.


Vignesh Subbian, PhD

Latest:

Managed Critical Care: Impact of Remote Decision-Making on Patient Outcomes

This work serves as a step toward better understanding the implications of remote critical care intervention by evaluating levels of tele–intensive care unit decision-making authority.


Erin Smith, JD

Latest:

Oncology Alternative Payment Models: Lessons From Commercial Insurance

Developing alternative payment models for commercial populations in specialties such as oncology is rife with practical challenges. Leading payers and practices share lessons to date.


Matthew Triplette, MD, MPH

Latest:

Factors Associated With Lung Cancer Risk Factor Documentation

This cross-sectional observational study found several factors associated with whether a patient had sufficient lung cancer risk factor documentation in the electronic health record.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo